VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 175 filers reported holding HAEMONETICS CORP in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2015$23,402,000
-33.7%
565,825
-28.0%
0.33%
-38.8%
Q1 2015$35,315,000
-46.2%
786,175
-55.2%
0.54%
-43.7%
Q4 2014$65,616,000
+21.8%
1,753,500
+13.7%
0.96%
+18.8%
Q3 2014$53,866,000
+17.0%
1,542,550
+18.2%
0.80%
+23.1%
Q2 2014$46,031,0001,304,7500.65%
Other shareholders
HAEMONETICS CORP shareholders Q2 2014
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders